Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00113581
Status:
COMPLETED
Last Update Posted:
2014-02-19
First Post:
2005-06-09
Brief Title:
Safety Study of EMD 72000 in Combination With ECX Epirubicin Cisplatin and Capecitabine in Oesophagogastric Cancer
Sponsor:
Merck KGaA Darmstadt Germany
Organization:
Merck KGaA Darmstadt Germany
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-10
Start Date Type:
None
Primary Completion Date:
2006-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-01
Completion Date Type:
ACTUAL
First Submit Date:
2005-06-09
First Submit QC Date:
June 9 2005
Study First Post Date:
2005-06-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-02-17
Last Update Post Date:
2014-02-19
Last Update Post Date Type:
ESTIMATED